1. Polypeptide N-Acetylgalactosaminyltransferase 14 (GALNT14) as a Chemosensitivity-Related Biomarker for Osteosarcoma
   Qiong Xi et al, 2023, Journal of Oncology CrossRef
2. Rs9679162 genotype predicts prognosis of real-world advanced hepatocellular carcinoma treated by sorafenib
   Chih-Lang Lin et al, 2023, Cancer Biomarkers CrossRef
3. The GALNT14 Genotype Predicts Postoperative Outcome of Pancreatic Ductal Adenocarcinoma
   Chun-Cheng Chiang et al, 2019, Journal of Clinical Medicine CrossRef
4. Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma
   Kung-Hao Liang et al, 2021, Biomedicines CrossRef
5. EFEMP2 Mediates GALNT14-Dependent Breast Cancer Cell Invasion
   Tao Zuo et al, 2018, Translational Oncology CrossRef
6. Genomic Analysis Identifies New Loci Associated With Motor Complications in Parkinson's Disease
   Ho-Sung Ryu et al, 2020, Frontiers in Neurology CrossRef
7. A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy
   Chen-Chun Lin et al, 2020, The Pharmacogenomics Journal CrossRef
8. The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic Review
   Guanwu Wang et al, 2022, Cancers CrossRef
9. GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers
   Wey-Ran Lin et al, 2020, International Journal of Molecular Sciences CrossRef